Despite decades of high vaccination coverage, pertussis has remained endemic and
reemerged as a public health problem in many countries in the past 2 decades. Waning of …

The global burden of disease caused by respiratory syncytial virus (RSV) is increasingly
recognised, not only in infants, but also in older adults (aged≥ 65 years). Advances in …

IDSA Disclaimer As of the time of this publication, updates have been made to IDSA's
Guidelines on the Diagnosis of COVID-19. For the most updated version of these guidelines …

Guidelines for the treatment of persons with influenza virus infection were prepared by an
Expert Panel of the Infectious Diseases Society of America. The evidence-based guidelines …

These clinical practice guidelines are an update of the guidelines published by the
Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza …

Background The treatment of symptomatic congenital cytomegalovirus (CMV) disease with
intravenous ganciclovir for 6 weeks has been shown to improve audiologic outcomes at 6 …

Antibody responses develop following SARS-CoV-2 infection, but little is known about their
epitope specificities, clonality, binding affinities, epitopes, and neutralizing activity. We …

Background Safe and effective vaccines against coronavirus disease 2019 (Covid-19) are
urgently needed in young children. Methods We conducted a phase 1 dose-finding study …

Importance Maternal immunization with tetanus toxoid, reduced diphtheria toxoid, and
acellular pertussis (Tdap) vaccine could prevent infant pertussis. Objective To evaluate the …

After its emergence in Wuhan, China, in late November or early December 2019, the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus rapidly spread globally …